Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups.

PubWeight™: 6.09‹?› | Rank: Top 1%

🔗 View Article (PMID 12402203)

Published in J Infect Dis on October 08, 2002

Authors

Guy Boivin1, Yacine Abed, Gilles Pelletier, Louisette Ruel, Danielle Moisan, Stéphanie Côté, Teresa C T Peret, Dean D Erdman, Larry J Anderson

Author Affiliations

1: Research Center in Infectious Diseases, Regional Virology Laboratory, Laval University, Quebec City, Canada. Guy.Boivin@crchul.ulaval.ca

Articles citing this

(truncated to the top 100)

Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med (2004) 7.71

Human metapneumovirus infections in hospitalized children. Emerg Infect Dis (2003) 3.99

Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis (2003) 3.66

Detection of respiratory viruses by molecular methods. Clin Microbiol Rev (2008) 3.03

Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis (2004) 2.96

Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol (2004) 2.88

Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis (2004) 2.35

The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br J Haematol (2008) 2.19

Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial. BMJ (2013) 2.11

Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy. J Clin Microbiol (2003) 2.04

Human metapneumovirus infection in Japanese children. J Clin Microbiol (2004) 2.02

Human metapneumovirus infection in the Canadian population. J Clin Microbiol (2003) 1.90

Epidemiology of human metapneumovirus. Clin Microbiol Rev (2006) 1.88

Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis (2012) 1.84

Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis (2003) 1.81

Bocavirus infection in hospitalized children, South Korea. Emerg Infect Dis (2006) 1.76

High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates. J Clin Microbiol (2003) 1.73

Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J Virol (2005) 1.68

Animal pneumoviruses: molecular genetics and pathogenesis. Clin Microbiol Rev (2004) 1.67

A prospective study comparing human metapneumovirus with other respiratory viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis (2005) 1.61

Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol (2006) 1.61

Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol (2005) 1.59

Global genetic diversity of human metapneumovirus fusion gene. Emerg Infect Dis (2004) 1.53

Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med (2008) 1.53

Emerging respiratory viruses: challenges and vaccine strategies. Clin Microbiol Rev (2006) 1.52

The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity. J Virol (2005) 1.50

Human metapneumovirus persists in BALB/c mice despite the presence of neutralizing antibodies. J Virol (2004) 1.49

High genetic diversity of the attachment (G) protein of human metapneumovirus. J Clin Microbiol (2004) 1.46

Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus. J Virol (2005) 1.44

Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus. J Clin Microbiol (2003) 1.44

Pathogenesis of human metapneumovirus lung infection in BALB/c mice and cotton rats. J Virol (2005) 1.42

Infection with human metapneumovirus predisposes mice to severe pneumococcal pneumonia. J Virol (2008) 1.41

Human Metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev (2011) 1.38

Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J Virol (2008) 1.37

Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations requiring hospitalization in adults. J Infect Dis (2005) 1.32

Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity. J Virol (2005) 1.32

Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract. Am J Pathol (2004) 1.31

Recovery of human metapneumovirus genetic lineages a and B from cloned cDNA. J Virol (2004) 1.27

Effects of human metapneumovirus and respiratory syncytial virus antigen insertion in two 3' proximal genome positions of bovine/human parainfluenza virus type 3 on virus replication and immunogenicity. J Virol (2003) 1.26

Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry. J Virol (2008) 1.26

The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol J (2012) 1.17

Human metapneumovirus genetic variability, South Africa. Emerg Infect Dis (2005) 1.15

An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in vero cells and does not alter tissue tropism in hamsters. J Virol (2005) 1.15

Seroepidemiology of human metapneumovirus (hMPV) on the basis of a novel enzyme-linked immunosorbent assay utilizing hMPV fusion protein expressed in recombinant vesicular stomatitis virus. J Clin Microbiol (2005) 1.14

Detection of human metapneumovirus antigens in nasopharyngeal secretions by an immunofluorescent-antibody test. J Clin Microbiol (2005) 1.13

Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates. J Virol (2006) 1.11

Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J Virol (2006) 1.10

The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB/c mice. J Virol (2005) 1.09

Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection. Antimicrob Agents Chemother (2006) 1.09

Identification of new respiratory viruses in the new millennium. Viruses (2015) 1.09

Human metapneumovirus infections in children. Emerg Infect Dis (2008) 1.08

Outbreak of human metapneumovirus detected by use of the Vero E6 cell line in isolates collected in Yamagata, Japan, in 2004 and 2005. J Clin Microbiol (2007) 1.07

T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J Virol (2008) 1.07

Human metapneumovirus and severity of respiratory syncytial virus disease. Emerg Infect Dis (2004) 1.06

Clinical and epidemiological comparison of human metapneumovirus and respiratory syncytial virus in seoul, Korea, 2003-2008. J Korean Med Sci (2010) 1.06

Airway epithelial cell response to human metapneumovirus infection. Virology (2007) 1.06

Respiratory viruses other than influenza virus: impact and therapeutic advances. Clin Microbiol Rev (2008) 1.05

Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling. J Gen Virol (2008) 1.05

Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells. J Immunol (2011) 1.03

Subversion of pulmonary dendritic cell function by paramyxovirus infections. J Immunol (2009) 1.02

A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J Virol (2007) 1.02

Aetiology of influenza-like illness in adults includes parainfluenzavirus type 4. J Med Microbiol (2009) 1.01

Viral infections in immunocompromised patients. Biol Blood Marrow Transplant (2011) 1.01

Human metapneumovirus: enhanced pulmonary disease in cotton rats immunized with formalin-inactivated virus vaccine and challenged. Vaccine (2007) 1.01

Cytotoxic T-lymphocyte epitope vaccination protects against human metapneumovirus infection and disease in mice. J Virol (2006) 1.00

Molecular epidemiology and evolution of human respiratory syncytial virus and human metapneumovirus. PLoS One (2011) 0.99

Role of metapneumovirus in viral respiratory infections in young children. J Clin Microbiol (2006) 0.99

Genetic variability of the G glycoprotein gene of human metapneumovirus. J Clin Microbiol (2004) 0.98

Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity. J Virol (2008) 0.98

Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo. J Virol (2005) 0.98

An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J Virol (2008) 0.98

Evaluation of a new rapid antigen test using immunochromatography for detection of human metapneumovirus in comparison with real-time PCR assay. J Clin Microbiol (2009) 0.97

Early reinfection with human metapneumovirus in an infant. J Clin Microbiol (2004) 0.96

Rapid detection of human metapneumovirus strains in nasopharyngeal aspirates and shell vial cultures by monoclonal antibodies. J Clin Microbiol (2005) 0.96

Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection. J Virol (2010) 0.95

Diversity in glycosaminoglycan binding amongst hMPV G protein lineages. Viruses (2012) 0.95

Structure and self-assembly of the calcium binding matrix protein of human metapneumovirus. Structure (2013) 0.95

Human metapneumovirus in adults: a short case series. Eur J Clin Microbiol Infect Dis (2006) 0.94

Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region. J Virol (2006) 0.94

Human metapneumovirus infections are associated with severe morbidity in hospitalized children of all ages. Epidemiol Infect (2013) 0.94

Molecular epidemiology of respiratory viruses in virus-induced asthma. Front Microbiol (2013) 0.93

Human metapneumovirus reinfection among children in Thailand determined by ELISA using purified soluble fusion protein. J Infect Dis (2008) 0.92

Age-associated aggravation of clinical disease after primary metapneumovirus infection of BALB/c mice. J Virol (2009) 0.91

Intracellular processing, glycosylation, and cell surface expression of human metapneumovirus attachment glycoprotein. J Virol (2007) 0.91

Human Metapneumovirus: An Important Cause of Respiratory Disease in Children and Adults. Curr Infect Dis Rep (2005) 0.91

Development and validation of an enzyme-linked immunosorbent assay for human metapneumovirus serology based on a recombinant viral protein. Clin Diagn Lab Immunol (2005) 0.91

Respiratory Infections in the U.S. Military: Recent Experience and Control. Clin Microbiol Rev (2015) 0.90

Analysis of replication kinetics of the human metapneumovirus in different cell lines by real-time PCR. J Clin Microbiol (2005) 0.89

Characterization of human metapneumovirus infections in Israel. J Clin Microbiol (2006) 0.89

Development and optimization of a direct plaque assay for human and avian metapneumoviruses. J Virol Methods (2012) 0.88

Human metapneumovirus infection in a hematopoietic stem cell transplant recipient with relapsed multiple myeloma and rapidly progressing lung cancer. J Clin Microbiol (2006) 0.87

Human metapneumovirus infection in hospitalized children with acute respiratory disease in Korea. J Korean Med Sci (2006) 0.87

Effects of aging on the adaptive immune response to respiratory virus infections. Aging health (2009) 0.86

Human metapneumovirus-associated atypical pneumonia and SARS. Emerg Infect Dis (2004) 0.86

Potential electrostatic interactions in multiple regions affect human metapneumovirus F-mediated membrane fusion. J Virol (2012) 0.86

An Evaluation of the Additive Effect of Natural Herbal Medicine on SARS or SARS-like Infectious Diseases in 2003: A Randomized, Double-blind, and Controlled Pilot Study. Evid Based Complement Alternat Med (2008) 0.86

Multi-year study of human metapneumovirus infection at a large US Midwestern Medical Referral Center. J Clin Virol (2006) 0.86

Roles of the putative integrin-binding motif of the human metapneumovirus fusion (f) protein in cell-cell fusion, viral infectivity, and pathogenesis. J Virol (2014) 0.86

Clinical findings and unusual epidemiologic characteristics of human metapneumovirus infections in children in the region of Basel, Switzerland. Eur J Pediatr (2007) 0.85

Characterization of human metapneumovirus infection of myeloid dendritic cells. Virology (2006) 0.85

Articles by these authors

Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71

A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55

Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34

A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27

Viral discovery and sequence recovery using DNA microarrays. PLoS Biol (2003) 5.95

Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA (2005) 5.84

Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. Pediatrics (2004) 5.74

Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis (2002) 5.64

Human metapneumovirus infections in young and elderly adults. J Infect Dis (2003) 4.91

Human metapneumovirus infections in hospitalized children. Emerg Infect Dis (2003) 3.99

Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses. J Clin Microbiol (2007) 3.95

Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep (2004) 3.84

Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis (2012) 3.35

Rhinovirus-associated hospitalizations in young children. J Infect Dis (2007) 3.35

An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med (2003) 3.32

Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis (2006) 3.26

Superiority of reverse-transcription polymerase chain reaction to conventional viral culture in the diagnosis of acute respiratory tract infections in children. J Infect Dis (2004) 3.25

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association. Proc Natl Acad Sci U S A (2004) 3.23

Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child. Emerg Infect Dis (2002) 3.13

In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clin Infect Dis (2003) 2.99

Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis. J Virol (2009) 2.96

Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus. Emerg Infect Dis (2004) 2.88

Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol (2006) 2.67

Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis (2007) 2.65

An outbreak of severe respiratory tract infection due to human metapneumovirus in a long-term care facility. Clin Infect Dis (2007) 2.63

Surveillance of eight respiratory viruses in clinical samples of pediatric patients in southeast Brazil. J Pediatr (Rio J) (2007) 2.53

Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep (2003) 2.53

Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. J Infect Dis (2010) 2.51

Human metapneumovirus infection among children hospitalized with acute respiratory illness. Emerg Infect Dis (2004) 2.35

Real-time PCR assays for detection of bocavirus in human specimens. J Clin Microbiol (2006) 2.29

Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol (2010) 2.29

Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med (2009) 2.24

[Clinical practice guidelines on the use of liver biopsy]. Gastroenterol Clin Biol (2002) 2.22

Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg (2012) 2.18

Simultaneous detection and high-throughput identification of a panel of RNA viruses causing respiratory tract infections. J Clin Microbiol (2007) 2.14

Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J (2012) 2.12

Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses. J Clin Microbiol (2008) 2.10

Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. Children. Pediatr Infect Dis J (2005) 2.07

Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol (2011) 2.07

Detection of novel SARS-like and other coronaviruses in bats from Kenya. Emerg Infect Dis (2009) 2.04

Human parechovirus 3 and neonatal infections. Emerg Infect Dis (2005) 2.02

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00

Quantitative real-time PCR assays for detection of human adenoviruses and identification of serotypes 40 and 41. Appl Environ Microbiol (2005) 1.96

Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains. Virus Res (2003) 1.96

Human coronavirus infections in rural Thailand: a comprehensive study using real-time reverse-transcription polymerase chain reaction assays. J Infect Dis (2007) 1.94

Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls. Pediatr Infect Dis J (2012) 1.93

Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis (2011) 1.93

Human metapneumovirus: a new player among respiratory viruses. Clin Infect Dis (2004) 1.92

Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin Infect Dis (2002) 1.92

Prediction of drainage effectiveness during endoscopic stenting of malignant hilar strictures: the role of liver volume assessment. Gastrointest Endosc (2010) 1.91

Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr (2009) 1.90

Novel human rhinoviruses and exacerbation of asthma in children. Emerg Infect Dis (2008) 1.87

Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics (2004) 1.83

GeneScan reverse transcription-PCR assay for detection of six common respiratory viruses in young children hospitalized with acute respiratory illness. J Clin Microbiol (2003) 1.83

Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog (2010) 1.81

Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol (2008) 1.80

Association of the CT values of real-time PCR of viral upper respiratory tract infection with clinical severity, Kenya. J Med Virol (2013) 1.80

Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. J Infect Dis (2009) 1.78

Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000. Emerg Infect Dis (2002) 1.78

Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus. J Clin Microbiol (2013) 1.76

Substantial variability in community respiratory syncytial virus season timing. Pediatr Infect Dis J (2003) 1.71

Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network. Pediatr Infect Dis J (2004) 1.69

A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J Infect Dis (2009) 1.66

Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerg Infect Dis (2004) 1.65

Hereditary persistence of alpha-fetoprotein is due to both proximal and distal hepatocyte nuclear factor-1 site mutations. Gastroenterology (2004) 1.65

Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors. J Infect Dis (2011) 1.64

Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial viruses. J Clin Microbiol (2004) 1.64

Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. Clin Infect Dis (2007) 1.63

Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform. Vaccine (2008) 1.48

Influenza virus resistance to neuraminidase inhibitors. Antiviral Res (2013) 1.47

Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus. PLoS Pathog (2009) 1.46

Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. J Immunol (2006) 1.45

Sequence polymorphism of the predicted human metapneumovirus G glycoprotein. J Gen Virol (2004) 1.44

Comparative evaluation of real-time PCR assays for detection of the human metapneumovirus. J Clin Microbiol (2003) 1.44

High titers of IgE antibody to dust mite allergen and risk for wheezing among asthmatic children infected with rhinovirus. J Allergy Clin Immunol (2012) 1.38

Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J (2003) 1.35

The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand. PLoS One (2010) 1.35

Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J (2011) 1.34

Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy. Vaccine (2007) 1.34

Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States. J Infect Dis (2010) 1.34

Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord. PLoS Genet (2008) 1.32

Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir. Antiviral Res (2006) 1.32

Two outbreaks of severe respiratory disease in nursing homes associated with rhinovirus. J Am Geriatr Soc (2006) 1.32